BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chart H, Scotland SM, Rowe B. Serum antibodies to Escherichia coli serotype O157:H7 in patients with hemolytic uremic syndrome. J Clin Microbiol 1989;27:285-90. [DOI: 10.1128/jcm.27.2.285-290.1989] [Cited by in Crossref: 75] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Cheasty T, Robertson R, Chart H, Mannion P, Syed Q, Garvey R, Rowe B. The use of serodiagnosis in the retrospective investigation of a nursery outbreak associated with Escherichia coli O157:H7. J Clin Pathol 1998;51:498-501. [PMID: 9797724 DOI: 10.1136/jcp.51.7.498] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
2 Rowe PC. Escherichia coli O157:H7, other verotoxin-producing E coli and the hemolytic uremic syndrome in childhood. Can J Infect Dis 1995;6:105-10. [PMID: 22416211 DOI: 10.1155/1995/803560] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
3 Evans J, Chalmers RM, Chart H, Salmon RL, Kench SM, Coleman TJ, Meadows D, Morgan-Capner P, Softley P, Sillis M, Thomas DR. Evidence of persisting serum antibodies to Escherichia coli O157 lipopolysaccharide and Verocytotoxin in members of rural communities in England. Eur J Epidemiol 2000;16:885-9. [PMID: 11338118 DOI: 10.1023/a:1011072907877] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
4 Johnson RP, Cray WC Jr, Johnson ST. Serum antibody responses of cattle following experimental infection with Escherichia coli O157:H7. Infect Immun 1996;64:1879-83. [PMID: 8613410 DOI: 10.1128/iai.64.5.1879-1883.1996] [Cited by in Crossref: 49] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
5 Kleanthous H, Smith HR, Scotland SM, Gross RJ, Rowe B, Taylor CM, Milford DV. Haemolytic uraemic syndromes in the British Isles, 1985-8: association with verocytotoxin producing Escherichia coli. Part 2: Microbiological aspects. Arch Dis Child 1990;65:722-7. [PMID: 2201262 DOI: 10.1136/adc.65.7.722] [Cited by in Crossref: 140] [Cited by in F6Publishing: 140] [Article Influence: 4.4] [Reference Citation Analysis]
6 Wijnsma KL, van Bommel SA, van der Velden T, Volokhina E, Schreuder MF, van den Heuvel LP, van de Kar NC. Fecal diagnostics in combination with serology: best test to establish STEC-HUS. Pediatr Nephrol 2016;31:2163-70. [PMID: 27240858 DOI: 10.1007/s00467-016-3420-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
7 Gunzer F, Karch H. Expression of A and B subunits of Shiga-like toxin II as fusions with glutathione S-transferase and their potential for use in seroepidemiology. J Clin Microbiol 1993;31:2604-10. [DOI: 10.1128/jcm.31.10.2604-2610.1993] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
8 Konadu E, Robbins JB, Shiloach J, Bryla DA, Szu SC. Preparation, characterization, and immunological properties in mice of Escherichia coli O157 O-specific polysaccharide-protein conjugate vaccines. Infect Immun 1994;62:5048-54. [DOI: 10.1128/iai.62.11.5048-5054.1994] [Cited by in Crossref: 37] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
9 Greatorex JS, Thorne GM. Humoral immune responses to Shiga-like toxins and Escherichia coli O157 lipopolysaccharide in hemolytic-uremic syndrome patients and healthy subjects. J Clin Microbiol 1994;32:1172-8. [DOI: 10.1128/jcm.32.5.1172-1178.1994] [Cited by in Crossref: 54] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
10 Li Y, Frey E, Mackenzie AM, Finlay BB. Human response to Escherichia coli O157:H7 infection: antibodies to secreted virulence factors. Infect Immun 2000;68:5090-5. [PMID: 10948130 DOI: 10.1128/IAI.68.9.5090-5095.2000] [Cited by in Crossref: 104] [Cited by in F6Publishing: 40] [Article Influence: 4.7] [Reference Citation Analysis]
11 Melli LJ, Ciocchini AE, Caillava AJ, Vozza N, Chinen I, Rivas M, Feldman MF, Ugalde JE, Comerci DJ. Serogroup-specific bacterial engineered glycoproteins as novel antigenic targets for diagnosis of shiga toxin-producing-escherichia coli-associated hemolytic-uremic syndrome. J Clin Microbiol 2015;53:528-38. [PMID: 25472487 DOI: 10.1128/JCM.02262-14] [Cited by in Crossref: 23] [Cited by in F6Publishing: 8] [Article Influence: 2.9] [Reference Citation Analysis]
12 Chart H, Rowe B, Baskerville A, Humphrey TJ. Serological response of chickens to Salmonella enteritidis infection. Epidemiol Infect 1990;104:63-71. [PMID: 2407544 DOI: 10.1017/s0950268800054534] [Cited by in Crossref: 42] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
13 Proulx F, Turgeon JP, Delage G, Lior H, Lafleur L, Chicoine L. Immune response to verotoxin 1 and 2 in children with Escherichia coli O157:H7 hemorrhagic colitis and classic hemolytic uremic syndrome. Can J Infect Dis 1995;6:136-40. [PMID: 22514385 DOI: 10.1155/1995/825478] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
14 Watanabe M, Connelly B, Weiss AA. Characterization of serological responses to pertussis. Clin Vaccine Immunol 2006;13:341-8. [PMID: 16522775 DOI: 10.1128/CVI.13.3.341-348.2006] [Cited by in Crossref: 37] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
15 Chart H, Cheasty T, Cope D, Gross RJ, Rowe B. The serological relationship between Yersinia enterocolitica O9 and Escherichia coli O157 using sera from patients with yersiniosis and haemolytic uraemic syndrome. Epidemiol Infect 1991;107:349-56. [PMID: 1936156 DOI: 10.1017/s0950268800048986] [Cited by in Crossref: 20] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
16 Chart H, Law D, Rowe B, Acheson DW. Patients with haemolytic uraemic syndrome caused by Escherichia coli O157: absence of antibodies to Vero cytotoxin 1 (VT1) or VT2. J Clin Pathol 1993;46:1053-4. [PMID: 8254096 DOI: 10.1136/jcp.46.11.1053] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.5] [Reference Citation Analysis]
17 Kimura R, Mandrell RE, Galland JC, Hyatt D, Riley LW. Restriction-site-specific PCR as a rapid test to detect enterohemorrhagic Escherichia coli O157:H7 strains in environmental samples. Appl Environ Microbiol 2000;66:2513-9. [PMID: 10831431 DOI: 10.1128/AEM.66.6.2513-2519.2000] [Cited by in Crossref: 22] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
18 Yamada S, Kai A, Kudoh Y. Serodiagnosis by passive hemagglutination test and verotoxin enzyme-linked immunosorbent assay of toxin-producing Escherichia coli infections in patients with hemolytic-uremic syndrome. J Clin Microbiol 1994;32:955-9. [DOI: 10.1128/jcm.32.4.955-959.1994] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
19 Nataro JP, Kaper JB. Diarrheagenic Escherichia coli. Clin Microbiol Rev 1998;11:142-201. [DOI: 10.1128/cmr.11.1.142] [Cited by in Crossref: 3111] [Cited by in F6Publishing: 1286] [Article Influence: 129.6] [Reference Citation Analysis]
20 Isobe J, Shima T, Kanatani J, Kimata K, Shimizu M, Kobayashi N, Tanaka T, Iyoda S, Ohnishi M, Sata T, Watahiki M. Serodiagnosis using microagglutination assay during the food-poisoning outbreak in Japan caused by consumption of raw beef contaminated with enterohemorrhagic Escherichia coli O111 and O157. J Clin Microbiol 2014;52:1112-8. [PMID: 24452161 DOI: 10.1128/JCM.03469-13] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
21 Chart H, Scotland SM, Smith HR, Rowe B. Antibodies to Escherichia coli O157 in patients with haemorrhagic colitis and haemolytic uraemic syndrome. J Clin Pathol 1989;42:973-6. [PMID: 2677053 DOI: 10.1136/jcp.42.9.973] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 0.8] [Reference Citation Analysis]
22 Hong S, Oh KH, Cho SH, Kim SH, Lee BK, Yoo SJ, Lim HS, Park MS. Anti-Shiga toxin immunoglobulin G antibodies in healthy South Korean slaughterhouse workers. Scand J Infect Dis 2012;44:168-73. [PMID: 22074490 DOI: 10.3109/00365548.2011.631574] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
23 Mackenzie AM, Lebel P, Orrbine E, Rowe PC, Hyde L, Chan F, Johnson W, McLaine PN. Sensitivities and specificities of premier E. coli O157 and premier EHEC enzyme immunoassays for diagnosis of infection with verotxin (Shiga-like toxin)-producing Escherichia coli. The SYNSORB Pk Study investigators. J Clin Microbiol 1998;36:1608-11. [PMID: 9620386 DOI: 10.1128/JCM.36.6.1608-1611.1998] [Cited by in Crossref: 45] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
24 Griener TP, Strecker JG, Humphries RM, Mulvey GL, Fuentealba C, Hancock RE, Armstrong GD. Lipopolysaccharide renders transgenic mice expressing human serum amyloid P component sensitive to Shiga toxin 2. PLoS One 2011;6:e21457. [PMID: 21731756 DOI: 10.1371/journal.pone.0021457] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
25 Chart H, van der Kar NC, Tolboom JJ, Monnens LM, Rowe B. Serological detection of verocytotoxin-producing Escherichia coli in patients with haemolytic uraemic syndrome in western Europe. Eur J Clin Microbiol Infect Dis 1993;12:707-9. [PMID: 7694851 DOI: 10.1007/BF02009386] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
26 Brook MG, Smith HR, Bannister BA, McConnell M, Chart H, Scotland SM, Sawyer A, Smith M, Rowe B. Prospective study of verocytotoxin-producing, enteroaggregative and diffusely adherent Escherichia coli in different diarrhoeal states. Epidemiol Infect 1994;112:63-7. [PMID: 8119365 DOI: 10.1017/s0950268800057423] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
27 Bitzan M, Ludwig K, Klemt M, König H, Büren J, Müller-Wiefel DE. The role of Escherichia coli O 157 infections in the classical (enteropathic) haemolytic uraemic syndrome: results of a Central European, multicentre study. Epidemiol Infect 1993;110:183-96. [PMID: 8472763 DOI: 10.1017/s0950268800068102] [Cited by in Crossref: 80] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
28 Chart H, Okubadejo OA, Rowe B. The serological relationship between Escherichia coli O157 and Yersinia enterocolitica O9 using sera from patients with brucellosis. Epidemiol Infect 1992;108:77-85. [PMID: 1547843 DOI: 10.1017/s0950268800049529] [Cited by in Crossref: 30] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
29 Smith HR, Scotland SM. ACP Broadsheet 135: January 1993. Isolation and identification methods for Escherichia coli O157 and other Vero cytotoxin producing strains. J Clin Pathol 1993;46:10-7. [PMID: 8432882 DOI: 10.1136/jcp.46.1.10] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 1.1] [Reference Citation Analysis]